> Back to Indiviual Listing
> Back to Drug Listing
AC Immune SA
EPFL Innovation Park, Building B
1015 Lausanne Switzerland
Website:
www.acimmune.com
Email:
info@acimmune.com
Phone:
011-41-21-693-91-21
Fax:
011-41-21-693-91-20
Number of Employees: 51-200
Revenue: $7,194,000 CHF
Swiss-based biopharmaceutical company focused on neurodegenerative diseases with four product candidates in clinical trials. The Company designs, discovers and develops therapeutic and diagnostic products intended to prevent and modify diseases caused by misfolding proteins. AC Immune's two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as Alzheimer's disease.
General Management
Marketing
R&D/Regulatory
Name
Title
Phone
Email
Andrea Pfeifer, PhD
Chief Executive Officer
andrea.pfeifer@acimmune.com
Jorg Hornstein
Chief Financial Officer
Jean-Fabien Monin
Chief Administrative Officer
jean-fabien.monin@acimmune.com
Bojana Portmann, PhD
AVP, IP & Business Development
Marie Kosco-Vilbois
Chief Scientific Officer
Julien Rongere, PhD
VP, Regulatory Affairs & Quality
Olivier Sol, MD
Medical Director
General Management
Andrea Pfeifer, PhD
Chief Executive Officer
andrea.pfeifer@acimmune.com
Jorg Hornstein
Chief Financial Officer
Jean-Fabien Monin
Chief Administrative Officer
jean-fabien.monin@acimmune.com
Marketing
Bojana Portmann, PhD
AVP, IP & Business Development
R&D/Regulatory
Marie Kosco-Vilbois
Chief Scientific Officer
Julien Rongere, PhD
VP, Regulatory Affairs & Quality
Olivier Sol, MD
Medical Director